CN Patent

CN105395528A — 依匹哌唑口腔速溶膜

Assigned to BEIJING KANG LISHENG PHARMACEUTICAL TECHNOLOGY DEVELOPMENT Co Ltd · Expires 2016-03-16 · 10y expired

What this patent protects

本发明涉及一种口腔内可即刻溶化的依匹哌唑口腔速溶膜剂,用于改善依匹哌唑的使用性能,属药物制剂领域。该口腔速溶膜包括药物活性成分和药学适用的辅料,药物活性成分为依匹哌唑,药学适用的辅料包括:成膜材料、增塑剂、吸收促进剂、矫味剂和其他辅料。此口腔速溶膜具有载药量高、厚度薄、口感良好且无需饮水即可在口腔内即刻溶化、口服吸收速度快的优点,解决了重度抑郁患者和精神分裂症患者服药顺应性差及藏药和吐药现象,特别适宜有吞咽困难的患者。

USPTO Abstract

本发明涉及一种口腔内可即刻溶化的依匹哌唑口腔速溶膜剂,用于改善依匹哌唑的使用性能,属药物制剂领域。该口腔速溶膜包括药物活性成分和药学适用的辅料,药物活性成分为依匹哌唑,药学适用的辅料包括:成膜材料、增塑剂、吸收促进剂、矫味剂和其他辅料。此口腔速溶膜具有载药量高、厚度薄、口感良好且无需饮水即可在口腔内即刻溶化、口服吸收速度快的优点,解决了重度抑郁患者和精神分裂症患者服药顺应性差及藏药和吐药现象,特别适宜有吞咽困难的患者。

Drugs covered by this patent

Patent Metadata

Patent number
CN105395528A
Jurisdiction
CN
Classification
Expires
2016-03-16
Drug substance claim
No
Drug product claim
No
Assignee
BEIJING KANG LISHENG PHARMACEUTICAL TECHNOLOGY DEVELOPMENT Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.